Hannover Rück stock: analysis & valuation

HNR1.DEInsurance - ReinsuranceGermanyData as of Nov 15, 2026
Metrics analysis · Insurance - Reinsurance

Hannover Rück HNR1.DE

Price 299.60 EUR +0.94%Market cap 36.1 bn EUR52 weeks 223.40 – 309.20
Forward P/E
12.5x
Industry 9.8x
Price/book
2.6x
Industry 1.5x
Revenue growth
2.2%
Industry -0.1%
Return on equity
21.4%
Industry 16.9%
Net margin
12.2%
Industry 11.7%
Dividend yield
4.2%
Industry 4.1%

What does Hannover Rück do?

Hannover Re is one of the world's largest reinsurers, headquartered in Hanover. The company assumes risks from primary insurers and other reinsurers and earns its income from the premiums it collects for doing so, as well as from returns on the investment of insurance funds. Its clients are insurance companies worldwide.

The business is divided into two segments: Property & Casualty reinsurance covers, among other things, natural catastrophes, aviation, marine, credit and surety risks, and cyber, and also includes alternative risk transfer solutions and parametric products. Life & Health reinsurance covers risks such as death, disability, critical illness, long-term care and longevity. In terms of competition, Hannover Re is among the leading providers alongside Munich Re, Swiss Re and SCOR. Its positioning rests on high financial strength, broad diversification across lines of business and regions, and long-standing client relationships.

Score profile

Quality5.6
Valuation0.6
Growth6.9
Financial strength7.5
Momentum9.2

Rank vs. Insurance - Reinsurance (8 companies). 10 = top of the group, 5 = middle. Calculated from the metrics below, without AI.

Metrics compared with the industry

On profitability and quality, Hannover Rück ranks in the middle in the group Insurance - Reinsurance (5.6/10). On growth, the company ranks above average in the group Insurance - Reinsurance (6.9/10). On valuation (higher = cheaper), the stock ranks in the bottom fifth in the group Insurance - Reinsurance (0.6/10). On financial strength, Hannover Rück ranks above average in the group Insurance - Reinsurance (7.5/10).

MetricStockGroup medianRanking
Forward P/E12.5x9.8xbetter than 6 %
Trailing P/E13.0x10.9xbetter than 6 %
PEG ratio5.5x1.6xbetter than 8 %
EV/EBITDA9.7x8.7xbetter than 30 %
Price/sales1.6x1.2xbetter than 6 %
Price/book2.6x1.5xbetter than 6 %
Revenue growth2.2%-0.1%better than 56 %
Earnings growth6.7%0.3%better than 81 %
Gross margin16.6%21.8%better than 31 %
Operating margin14.6%14.8%better than 44 %
Net margin12.2%11.7%better than 69 %
Return on equity21.4%16.9%better than 81 %
Debt/equity28.2%29.6%better than 56 %
Current ratio0.2x0.8xbetter than 6 %
Free cash flow yield12.8%10.9%better than 69 %
Dividend yield4.2%4.1%–
Payout ratio54.3%45.0%–
Beta0.090.29–

Valuation: what is Hannover Rück worth?

Two valuation approaches – a discounted cash flow model and a valuation at the industry’s median multiples – give Hannover Rück a model range of 165.12 EUR to 234.11 EUR per share.

Price 299.60 EUR
Analysts 285.47 EUR
Fair value range 165.12 EUR – 234.11 EURMidpoint 199.62 EUR (−33.4% vs. price)

15 analysts, average rating “Hold”, average price target 285.47 EUR (−4.7%).

The full DCF matrix, the reverse DCF (what growth the price implies) and scenarios are part of the Pro analysis.

What the business depends on

  • Premium volume depends on primary insurers' demand for risk transfer and on the price level in the reinsurance market.
  • Underwriting profit is determined by how well risks are selected, priced and spread across lines of business and regions.
  • Investment income from insurance reserves contributes significantly to earnings and depends on the interest rate environment.

Risks

  • Large losses from natural catastrophes or other extreme events can weigh heavily on results in individual periods.
  • Insufficient loss reserves may require later reserve strengthening, particularly in long-tail liability lines.
  • Softer market prices, capital market fluctuations and regulatory changes can put pressure on profitability and capitalization.

What to look for with Hannover Rück

The combined ratio shows whether the insurance business is profitable before investment income, and thus reveals the quality of risk selection and pricing.

Full AI analysis of Hannover Rück

The AI evaluates all the numbers above and turns them into an assessment with a score, strengths and weaknesses, a fair value range and risks – from €1.99; Plus (€4.99) adds business model, moat and scenarios, Pro (€9.99) also peer comparison and reverse DCF. See an example.

Analyze a stock

Results in minutes
1 Choose a stock
2 Choose the depth

See what you get first: Example Compact (Apple) PDF Plus example (Microsoft) PDF Example Pro (NVIDIA) PDF

3 Delivery
Secure payment via Stripe Report by email + PDF No subscription

Frequently asked questions about Hannover Rück stock

What is the P/E ratio of Hannover Rück stock?

Based on expected earnings, Hannover Rück trades at a P/E of 12.5x, compared with a median of 9.8x for the peer group Insurance - Reinsurance. Based on the earnings of the last twelve months it is 13.0x. (data as of Nov 15, 2026)

Does Hannover Rück pay a dividend?

Yes. The dividend yield is currently 4.2%, with a payout ratio of 54.3% of earnings.

Is Hannover Rück stock undervalued?

Measured by valuation metrics (P/E, EV/EBITDA, price/sales, PEG), Hannover Rück is currently valued more expensive than most companies in the group Insurance - Reinsurance (valuation score 0.6 out of 10). Our model calculations (DCF and industry multiples) give a range of 165.12 EUR to 234.11 EUR per share at a price of 299.60 EUR. This is a model calculation, not an investment recommendation.

What do analysts say about Hannover Rück stock?

15 analysts have an average price target of 285.47 EUR (−4.7% vs. the current price); the average rating is “Hold”. Analyst targets are opinions and change frequently.

Comparable stocks

All information without guarantee. Metrics from public market data, updated daily; company profile written editorially with the help of AI. Not investment advice and not a solicitation to buy or sell securities.